Source link : https://newshealth.biz/health-news/mavacamten-no-match-for-nonobstructive-hcm-in-phase-iii-trial/
(MedPage Today) — MADRID — Mavacamten (Camzyos) failed to replicate its previous successes in hypertrophic cardiomyopathy (HCM) when applied to a population with symptomatic, nonobstructive disease, the phase III ODYSSEY-HCM trial showed…. Source link : https://www.medpagetoday.com/meetingcoverage/esc/117243 Author : Publish date : 2025-08-30 15:20:00 Copyright for syndicated content belongs to the linked Source.
The post Mavacamten No Match for Nonobstructive HCM in Phase III Trial first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-30 15:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8